title: [Mixed facial lymphatic malformation: case report].
abstract: Lymphangiomas are a common form of vascular malformation of the lymphatic vessels, mainly in the head and neck region. Most cases are progressive evolution and require a multidisciplinary approach. Currently, the first therapeutic option is sclerotherapy, leaving surgery for the treatment of remaining lesions.
  
  
  OBJECTIVE
  To present a case of facial lymphatic malformation (LM) treated with sclerotherapy, surgery and orthodontics in a 15-year follow up.
  
  
  METHODS
  A one-year-old female patient who consulted health professionals due to a progressive volume increase of the soft parts of her right cheek. The imaging study confirmed the diagnosis of microcystic lymphatic malformation. It was managed with OK-432 sclerotherapy and Bleomycin. At 2 years of age, the patient response was considered adequate; an intralesional submandibular surgical excision was then performed, with partial resection of the lesion. The biopsy confirmed the diagnosis of microcystic LM. Six months after, a re-resection was planned using the same approach and removing the remaining lesion, with favorable development until the age of 9 years when the patient required surgery and orthodontic management due to intraoral recurrence. No major developments until the age of 13 when a new orthodontic surgery and handling are planned to perform right oral commissure suspension.
  
  
  CONCLUSIONS
  LM management by sclerotherapy, surgery, and orthodontics has shown the advantages of a multidisciplinary long-term treatment in this case.
authors.forename: Carmen Gloria
authors.initials: CG
authors.lastname: Morovic I
authors.forename: Claudia
authors.initials: C
authors.lastname: Vidal T
authors.forename: Noemí
authors.initials: N
authors.lastname: Leiva V
authors.forename: Sebastián
authors.initials: S
authors.lastname: Véliz M
mesh_terms: D000293:Adolescent; D001761:Bleomycin / Q000008:administration & dosage; D002648:Child; D002675:Child, Preschool; D005153:Facial Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D008202:Lymphangioma / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D044148:Lymphatic Abnormalities / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D009971:Orthodontics, Corrective / Q000379:methods; D010844:Picibanil / Q000008:administration & dosage; D015911:Sclerotherapy / Q000379:methods*
chemical_list: D001761:Bleomycin; D010844:Picibanil